Iron chelation therapy in transfusion dependent patients with myelodysplastic syndrome with transfusional iron-overload in routine clinical management - interim analysis of the non-interventional study EXSEPT

被引：0
|
作者：
Nolte, F. [1 ]
Rubanov, O. [2 ]
Kuehn, R-B
Schumann, C. [1 ]
Kreil, S. [1 ]
Metzgeroth, G. [1 ]
Junkes, A. [3 ]
Johr, C. [3 ]
Albrecht, S. [3 ]
Hofmann, W-K [1 ]
机构：
[1] Univ Med Mannheim, Mannheim, Germany
[2] Off Based Hematol Oncol Specialist, Hamein, Germany
[3] Novartis Pharma GmbH, Nurnberg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2014年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P770
引用
收藏
页码：251 / 251
页数：1
相关论文
共 50 条
  • [1] IRON CHELATION THERAPY IN MYELODYSPLASTIC SYNDROME (MDS) IN ROUTINE CLINICAL SETTING: AN INTERIM ANALYSIS OF THE NON-INTERVENTIONAL STUDY EXSEPT
    Nolte, F.
    Rubanov, O.
    Kuehn, R. -B.
    Schumann, C.
    Kreil, S.
    Metzgeroth, G.
    Johr, C.
    Albrecht, S.
    Hofmann, W. -K.
    HAEMATOLOGICA, 2015, 100 : 490 - 490
  • [2] Efficacy and safety of deferasirox in routine clinical management of transfusion-dependent patients with iron overload - interim analysis of the non-interventional study EXSEPT
    Schumann, C.
    Nolte, F.
    Rubanov, O.
    Kuehn, R-B
    Kreil, S.
    Metzgeroth, G.
    Junkes, A.
    Johr, C.
    Albrecht, S.
    Hofmann, W-K
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 78 - 78
  • [3] CONIFER - Non-Interventional Study to Evaluate Therapy Monitoring During Deferasirox Treatment of Iron Toxicity in Myelodysplastic Syndrome Patients with Transfusional Iron Overload
    Bruch, Harald-Robert
    Dencausse, Yves
    Hessling, Joerg
    Michl, Gerlinde
    Schlag, Rudolf
    Skorupa, Alexandra
    Schneider-Schranz, Cornelia
    Wolf, Sebastian
    Schulte, Clemens
    Tesch, Hans
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 (7-8) : 424 - 431
  • [4] Guidelines on iron chelation therapy in patients with myelodysplastic syndrome and transfusion iron overload
    Gattermann, N.
    LEUKEMIA RESEARCH, 2007, 31 : S15 - S16
  • [5] Guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload
    Gattermann, Norbert
    LEUKEMIA RESEARCH, 2007, 31 : S10 - S15
  • [6] Deferasirox in the routine-treatment of MDS patients with chronic iron overload: interim results from the non-interventional, prospective study EXSEPT
    Nolte, F.
    Schumann, C.
    Bueckner, U.
    Schmidt, B.
    Hebart, H.
    Rubanov, O.
    Kuehn, R-B
    Kreil, S.
    Metzgeroth, G.
    Johrs, C.
    Albrecht, S.
    Bach, T.
    Hofmann, W-K
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 60 - 60
  • [7] Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload
    Gattermann, Norbert
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2008, 88 (01) : 24 - 29
  • [8] Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload
    Norbert Gattermann
    International Journal of Hematology, 2008, 88 : 24 - 29
  • [9] IRON OVERLOAD AND IRON CHELATION THERAPY WITH DEFERASIROX IN TRANSFUSION-DEPENDENT PATIENTS WITH MYELODYSPLASTIC SYNDROMES
    Del Corso, L.
    Bacigalupo, A.
    Balleari, E.
    Bellodi, A.
    Calzamiglia, T.
    Da Col, A.
    D'elia, P.
    Dominietto, A.
    Favorini, S.
    Forni, G.
    Galimberti, S.
    Ghio, M.
    Ghio, R.
    Salvetti, C.
    Ubezio, G.
    Vignolo, L.
    Molinari, E.
    Ghiso, A.
    Drousseau, M.
    Simonetti, F.
    Goretti, R.
    Tassara, R.
    Racchi, O.
    Scudeletti, M.
    Arboscello, E.
    Gianluca, F.
    LEUKEMIA RESEARCH, 2015, 39 : S150 - S150
  • [10] Iron chelation therapy in patients with transfusion-dependent myelodysplastic syndrome
    Mast, Alan E.
    Field, Joshua J.
    TRANSFUSION, 2012, 52 (10) : 2078 - 2080
12345